PEOPLE - Spectranetics makes appointment:
This article was originally published in Clinica
Spectranetics (Colorado Springs, Colorado) has appointed Kelly Elliott as vice-president of clinical affairs. She will be responsible for planning and implementing clinical research initiatives. Senior positions held by Ms Elliott include director of clinical research for Novoste. Spectranetics develops, manufactures and markets single-use medical devices for minimally invasive cardiovascular surgery.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.